Gmo Benchmark-free Mutual Fund Money Managers

GBMSX Fund  USD 26.18  0.18  0.69%   
Break down of Gmo Benchmark-free's management performance can provide insight into the fund's overall performance. Note that fund manager's attribution analysis is becoming a valuable factor that both investors and analysts use to determine the amount of risk that may be associated with Gmo Benchmark-free's future under-performance.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gmo Benchmark Free Allocation. Also, note that the market value of any mutual fund could be closely tied with the direction of predictive economic indicators such as signals in state.
Symbol  GBMSX
Name  Gmo Benchmark Free Allocation
TypeMutual Fund
Country  
 United States
Exchange  NMFQS

Information on Gmo Benchmark Free Allocation Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Gmo Benchmark-free Net Asset Comparison

Gmo Benchmark Free Allocation is one of the top funds in net asset among similar funds. Total Asset Under Management (AUM) of World Allocation category is currently estimated at about 5.06 Billion. Gmo Benchmark-free totals roughly 3.86 Billion in net asset claiming about 76% of World Allocation category.

Gmo Benchmark Free Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Gmo Benchmark Free Price Series Summation is a cross summation of Gmo Benchmark-free price series and its benchmark/peer.

About Gmo Benchmark-free Management Performance

The success or failure of an entity such as Gmo Benchmark Free often depends on how effective the management is. Gmo Benchmark-free management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Gmo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Gmo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
The fund is structured as a fund of funds and gains its investment exposures primarily by investing in Implementation fund. In addition, the fund may invest in any other GMO fund, whether now existing or created in the future. These underlying GMO Funds may include, among others, Opportunistic Income fund, Emerging Country Debt fund, High Yield fund, and the Alternative funds. The fund is permitted to invest in any asset class, strategy, sector, country, or region, and at times may have substantial exposure to a single asset class, sector, country, region, or currency or companies with similar market capitalizations.
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.

Gmo Benchmark Free Annual Yield

In accordance with the recently published financial statements, Gmo Benchmark Free Allocation has an Annual Yield of 0.0567%. This is 97.7% lower than that of the GMO family and significantly higher than that of the World Allocation category. The annual yield for all United States funds is notably lower than that of the firm.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.

Other Information on Investing in Gmo Mutual Fund

Gmo Benchmark-free financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Benchmark-free security.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets